Clinical Trial Update: Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update exploring minimizing radioactive iodine ablation after thyroid remnant in differentiated thyroid cancer (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Thyroid Neoplasms | Phase 2, Phase 3 | Status: UNKNOWN